Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version...

by Baba Psalm Duniya Inusa, Atoyebi Wale, Abdul Aziz Hassan, Tushar Idhate, Livingstone Dogara, Ifeoma Ijei, Yewen Qin, Kofi Anie, Juliana Olufunke Lawson, Lewis Hsu
Published 2018-09-01

Utilising the ‘Getting to Outcomes^®’ Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Niger...

by Baba P.D. Inusa, Kofi A. Anie, Andrea Lamont, Livingstone G. Dogara, Bola Ojo, Ifeoma Ijei, Wale Atoyebi, Larai Gwani, Esther Gani, Lewis Hsu
Published 2018-11-01